Award

University of North Carolina at Chapel Hill 1R61AI197035-01

Ultra-long-acting in-situ forming implant (ISFI) as a subcutaneous injection for prevention of HIV and unplanned pregnancy

Recipient

University of North Carolina at Chapel Hill

Award Amount

$1,106,984.00

Ceiling

$1,106,984.00

Awarded

April 17, 2026

Identifier

1R61AI197035-01

NIH grant awarded to University of North Carolina at Chapel Hill for developing a long-acting injectable implant to prevent HIV and unplanned pregnancy, with a budget of about $1.1 million for 2026.

Description

This is a NIH grant project focused on developing a long-acting injectable formulation for HIV and pregnancy prevention, with a budget of approximately $1,106,984 for fiscal year 2026. The project involves preclinical evaluation, formulation development, and plans for clinical translation.

View original record